iPLATO’s mobile health solutions have proven to transform patient services and reduce health inequalities across populations. Responding to international demand for mHealth the company is currently expanding into the United States, India and Europe.

Serving millions of patients and thousands of healthcare professionals every day iPLATO  has emerged as the leader in mobile health. Across this network, participating healthcare organisations use iPLATO solutions to promote smoking cessation, weight loss, childhood immunisation, vascular checks and cancer screening as well as offer mobile services for people with diabetes, hypertension, epilepsy and HIV. [Read More]




iPLATO careSUPPORT underpins our healthcare provider partners long term condition management and behavioural change programmes. It consists of a comprehensive range of modules to support patient self care.

A selection of iPLATO careSUPPORT modules:

  • Medication Support - to improve patient adherence to medication.
  • Carer Support - to make life easier for carers.
  • Education Support - to increase motivation for treatment.
  • Patient Diary - to enable self monitoring, reporting and sharing.
  • Text Consultation - to allow auditable doctor-patient interaction.

Long term condition management and behavioural change is an area of rapid growth for iPLATO and mHealth. Our target conditions are:

  • Epilepsy
  • HIV
  • Diabetes
  • Hypertension
  • Asthma
  • Depression
  • Smoking Cessation
  • Weight Loss
  • Physical Inactivity

We welcome innovative clinicians and academic institutions to get in touch to work with us to trial new concepts and develop new evidence.


iPLATO enrols 40 GP practices onto its “Friends & Family Test” service in just three weeks

London, 08 September 2014 - iPLATO, the leader in mHealth and Analytics, announced today that it has enrolled 40 GP practices in its ‘beta’ service for Friends & Family Testing (FFT) between mid-August and the first week of September. New rules mean that GP practices in England must start capturing patient feedback on their performance, in a similar scheme to that used by Hospitals. The high response rate to the ‘beta’ trial shows that GP’s are interested in a simple, cost effective plug-and-play solution that ensures they comply with the new regulations prior to the December 1, 2014 deadline. The FFT service from iPLATO meets NHS reporting requirements, takes 10 minutes to set up, and requires no knowledge, technology or training from the practice all for fully inclusive, capped cost.

 [Read More]

iPLATO set to help General Practice reach Government Immunisation Targets

London, 20 August 2014 - iPLATO is the UK leader in mHealth and a preferred provider for surgery - patient communications across general practice. Over the next few weeks, on behalf of all GP’s across the UK, iPLATO will facilitate the delivery of alerts, advice and support about flu jabs to millions of patients.

 [Read More]

iPLATO Research concludes: patients are (mostly) good

London, 10 July 2014 - Recent research from Imperial College London suggests that almost six million patients a year are turning to A&E because they cannot get an appointment with their GP. At the same time, iPLATO Research published a report concluded that 180,000 people used the iPLATO system to cancel their appointment during the 2013/14 financial year.

 [Read More]

[Back to Top]